Last reviewed · How we verify

NCT05720013

Acute Effects of Beetroot Juice on Locomotor Economy and Capacity in Chronic Stroke

Completed NA Last updated 22 May 2024
What this trial tests

NA trial testing Beetroot Juice supplement in Stroke in 22 participants. Completed in 31 December 2023.

Timeline
1 February 2023
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorIndiana University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment22
Start date1 February 2023
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Indiana University

Who can join

Adults 18 to 89, any sex, with Stroke or CVA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate if a beetroot juice supplement can improve oxygen capacity during walking tasks at a submaximal and maximal effort in people greater than 6 months following stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Indiana University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05720013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing